Davita Inc (NYSE:DVA) insider James K. Hilger sold 3,572 shares of the firm’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total value of $282,009.40. Following the transaction, the insider now directly owns 33,649 shares in the company, valued at $2,656,588.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Davita Inc (DVA) opened at $78.61 on Friday. The stock has a market capitalization of $14,332.23, a PE ratio of 30.23 and a beta of 0.96. Davita Inc has a fifty-two week low of $52.51 and a fifty-two week high of $80.71. The company has a current ratio of 1.40, a quick ratio of 1.35 and a debt-to-equity ratio of 1.79.
Davita (NYSE:DVA) last released its earnings results on Tuesday, November 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.13). The firm had revenue of $3.92 billion for the quarter, compared to analyst estimates of $3.91 billion. Davita had a return on equity of 13.31% and a net margin of 3.40%. Davita’s revenue was up 5.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.95 earnings per share. analysts anticipate that Davita Inc will post 3.42 EPS for the current year.
Davita declared that its board has initiated a share repurchase program on Tuesday, October 10th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.
A number of large investors have recently added to or reduced their stakes in DVA. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Davita in the 3rd quarter valued at $154,000. Country Club Trust Company n.a. acquired a new position in shares of Davita in the 4th quarter valued at $207,000. Berkshire Asset Management LLC PA acquired a new position in shares of Davita in the 4th quarter valued at $234,000. Oakbrook Investments LLC acquired a new position in shares of Davita in the 4th quarter valued at $415,000. Finally, CAPROCK Group Inc. boosted its position in shares of Davita by 53.2% in the 4th quarter. CAPROCK Group Inc. now owns 6,290 shares of the company’s stock valued at $498,000 after purchasing an additional 2,183 shares during the period. 87.97% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have recently commented on the company. Robert W. Baird reissued a “buy” rating and set a $95.00 price target (up from $82.00) on shares of Davita in a report on Friday, January 12th. Bank of America reissued a “buy” rating and set a $92.00 price target (up from $85.00) on shares of Davita in a report on Thursday, January 11th. TheStreet raised Davita from a “c” rating to a “b-” rating in a report on Thursday, January 4th. Zacks Investment Research raised Davita from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 2nd. Finally, SunTrust Banks set a $75.00 target price on Davita and gave the stock a “hold” rating in a report on Thursday, December 21st. Two analysts have rated the stock with a sell rating, five have given a hold rating, four have given a buy rating and two have assigned a strong buy rating to the company’s stock. Davita currently has a consensus rating of “Hold” and a consensus price target of $78.22.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.